Current treatment for erectile dysfunction: an umbrella review of systematic reviews and meta-analyses.

Researchers conducted a comprehensive umbrella review examining all available evidence on treatments for erectile dysfunction (ED). They analyzed 23 published meta-analyses covering 36 different treatment approaches, including both medications and non-drug therapies. The study evaluated treatment effectiveness using standardized measures of erectile function and hardness scores. The findings revealed that while many treatments showed statistical improvements in ED symptoms, the overall quality of the evidence supporting these treatments was disappointingly poor. More than half of the studies were rated as critically low quality, and when examining individual treatment effects, nearly 95% of the evidence was classified as low or very low quality. Only one study achieved a high-quality rating. The researchers noted that most studies involved limited numbers of patients and relied on subjective self-reported outcomes, which can be less reliable than objective measures. This means that while various treatments—including acupuncture, medications, devices, and other therapies—appear to help with ED, patients and healthcare providers should approach these findings with appropriate caution. The study highlights a significant gap in reliable, high-quality research on ED treatments. For patients considering any treatment option for ED, including acupuncture, these results underscore the importance of having realistic expectations and discussing all available options with healthcare providers. If you're considering acupuncture for erectile dysfunction, seek a licensed acupuncturist with specific experience treating men's health conditions.

This umbrella review analyzed 23 meta-analyses encompassing 42 summary effects across 36 interventions for erectile dysfunction, using IIEF variants and EHS as endpoints. Methodological quality assessment via AMSTAR-2 revealed concerning deficiencies: 56.5% of meta-analyses rated critically low quality, 30.5% low quality, 8.7% moderate quality, and only 4.3% high quality. Among individual summary effects, 47.6% were rated low quality and 47.6% very low quality, with just two achieving high or moderate ratings. Despite statistically significant improvements observed across both pharmacological and nonpharmacological interventions, the evidence base is compromised by small sample sizes and reliance on subjective outcome measures. The review identified 1,191 initial studies from major databases through October 2025. Clinical takeaway: Current evidence supporting ED treatments, including complementary approaches, remains predominantly weak. Practitioners should counsel patients about the limited reliability of existing research while acknowledging potential benefits, and advocate for participation in well-designed clinical trials to strengthen the evidence base.